Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
Holding DRMA?
Track your performance easily

Dermata Therapeutics (DRMA) Financial Statements

104 Followers

Dermata Therapeutics Financial Overview

Dermata Therapeutics's market cap is currently ―. The company's EPS TTM is $-27.469; its P/E ratio is -0.08; Dermata Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-2.64. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 6.90M---
Gross Profit-$ 6.90M---
EBIT$ -2.83M$ -3.13M$ -2.22M$ -1.81M$ -1.73M
EBITDA$ -2.83M$ -3.13M$ -2.22M$ -1.81M$ -1.73M
Net Income Common Stockholders$ -2.83M$ -3.13M$ -2.13M$ -1.72M$ -1.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 6.63M$ 8.44M
Total Assets$ 5.24M$ 5.18M$ 7.98M$ 7.32M$ 8.71M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 0.00$ 0.00$ 0.00$ -6.63M$ -8.44M
Total Liabilities$ 1.92M$ 1.37M$ 1.62M$ 916.82K$ 682.86K
Stockholders Equity$ 3.32M$ 3.81M$ 6.36M$ 6.41M$ 8.03M
Cash Flow-
Free Cash Flow$ -2.13M$ -2.70M$ -1.15M$ -1.77M$ -1.84M
Operating Cash Flow$ -2.13M$ -2.70M$ -1.15M$ -1.77M$ -1.84M
Investing Cash Flow-----
Financing Cash Flow$ 2.34M-$ 1.95M$ -35.42K$ 1.51M
Currency in USD

Dermata Therapeutics Earnings and Revenue History

Dermata Therapeutics Debt to Assets

Dermata Therapeutics Cash Flow

Dermata Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis